drug

MPP-S

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Charite University, Berlin, Germany
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

1
Modified Psychodynamic Psychotherapy for Patients With Schizophrenia
NCT02576613—Completed

KOLs & investigators

1
Christiane Montag, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Charite University, Berlin, Germany
company
trial
Modified Psychodynamic Psychotherapy for Patients With Schizophrenia
NA
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication
KOL
Christiane Montag, MD
KOL score —
person